152 related articles for article (PubMed ID: 38351666)
1. Method validation and characterization of stress degradation products of azelastine hydrochloride using LC-UV/PDA and LC-Q/TOF-MS studies.
Shekhar S; Bali A
Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9712. PubMed ID: 38351666
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of stress degradation products of febuxostat employing ultra-performance liquid chromatography-ultraviolet/photodiode array and liquid chromatography-mass spectrometry/time-of-flight studies.
Saha M; Bali A; Patra SR; Singh J
Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9423. PubMed ID: 36278931
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of stress degradation products of ibrutinib by LC-UV/PDA and LC-Q/TOF-MS studies.
Mondal B; Bali A; Sharma T
Eur J Mass Spectrom (Chichester); 2023 Aug; 29(4):248-261. PubMed ID: 37612237
[TBL] [Abstract][Full Text] [Related]
4. Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.
Mahesh M; Bali A; Gupta T
Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9745. PubMed ID: 38591150
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC-MS/TOF and MS(n) studies.
Chadha R; Bali A; Bansal G
J Pharm Biomed Anal; 2016 Jan; 118():139-148. PubMed ID: 26547261
[TBL] [Abstract][Full Text] [Related]
6. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
Chadha R; Bali A; Bansal G
J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
[TBL] [Abstract][Full Text] [Related]
7. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
[TBL] [Abstract][Full Text] [Related]
8. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
[TBL] [Abstract][Full Text] [Related]
9. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
10. Potential degradation products of abemaciclib: Identification and structural characterization employing LC-Q/TOF-MS and NMR including mechanistic explanation.
Kathar N; Rajput N; Jadav T; Sengupta P
J Pharm Biomed Anal; 2024 Jan; 237():115762. PubMed ID: 37844364
[TBL] [Abstract][Full Text] [Related]
11. Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.
Matta A; Sundararajan R
Rapid Commun Mass Spectrom; 2024 Feb; 38(3):e9676. PubMed ID: 38211348
[TBL] [Abstract][Full Text] [Related]
12. Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products.
Thalluri B; Dhiman V; Tiwari S; Baira SM; Kumar Talluri MVN
J Pharm Biomed Anal; 2020 Feb; 179():112985. PubMed ID: 31780282
[TBL] [Abstract][Full Text] [Related]
13. Study on the hydrolytic degradation behaviour of bictegravir by LC-PDA-Q/TOF-MS/MS NMR and in silico toxicity assessment.
Dannarm SR; Harini D; Reddy GN; Ali N; Sonti R
J Pharm Biomed Anal; 2024 Feb; 239():115909. PubMed ID: 38104374
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
[TBL] [Abstract][Full Text] [Related]
15. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
[TBL] [Abstract][Full Text] [Related]
16. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
[TBL] [Abstract][Full Text] [Related]
18. Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity.
Dhiman V; Balhara A; Singh S; Tiwari S; Gananadhamu S; Talluri MVNK
J Pharm Biomed Anal; 2021 May; 199():114037. PubMed ID: 33836462
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
[TBL] [Abstract][Full Text] [Related]
20. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
